Systolic and diastolic dysfunction of left in NIDDM patients;Zaburzenia funkcji skurczowej i rozkurczowej lewej komory u chorych z cukrzyca̧ i niemym niedokrwieniem

Polski Przeglad Kardiologiczny

Volumn 5, Issue 1, 2003, Pages 25-32

  Mamcarz, Artur ^a   Braksator, Wojciech ^a   Światowiec, Andrzej ^a   Krzyzanowski, Wojciech ^b   Syska Sumińska, Joanna ^a   Kuch, Marek ^a   Kuch, Jerzy ^a   Dłuzniewski, Mirosław ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b Oddział Wewnetrzny Szpitala ^*  (Poland)

Author keywords

Diastolic dysfunction; Non insulin dependent diabetes mellitus; Silent myocardial ischemia

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR PROCEDURES; CARDIOVASCULAR RISK; CONTROLLED STUDY; DECELERATION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; FOLLOW UP; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE OVERLOAD; HEART VOLUME; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METABOLIC BALANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; RELAXATION TIME; RISK FACTOR; SILENT MYOCARDIAL ISCHEMIA;

EID: 0037257341     PISSN: 15075540     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Braunwald E.: Heart disease: Textbook of cardiovascular medicine. Wyd. 6. W.B. Saunders Company, New York, 2001.
2. Feigenbaum H.: Echocardiography. Wyd. 5. Lea&Febiger, Philadelphia, 1994.
3. 2+ - exchanger protein levels and diastolic function of failing human myocardium. Circulation, 1999, 99, 641-648.
4. Wierzbowska K., Krzemińska-Pakuła M., Kasprzak J.D.: Zastosowanie zaawansowanych metod echokardiograficznych dla oceny funkcji rozkurczowej lewej komory serca. Pol. Przegl. Kardiol., 2001, 3, 273-282.
5. Lubien E., De Maria A., Krishnaswamy P. i wsp.: Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation, 2002, 105, 595-601.
6. Ommen S.: Echocardiographic assessment of diastolic function. Curr. Opin. Cardiol., 2001, 16, 240-245.
7. Bogaty P., Mure P., Dumesnil J.G.: New insights into diastolic dysfunction as the cause of acute left-sided heart failure associated with systemic hypertension and/or coronary artery disease. Am. J. Cardiol., 2002, 89, 341-345.
8. Fernandez-Funez A., Cabrera Sole R., Hernandez A. i wsp.: Effect of captopril on left ventricular diastolic dysfunction in young insulin dependent diabetic patients with microalbuminuria. Med. Clin., 2002, 118, 321-326.
9. Zile M.R., Brutsaert D.L.: New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation, 2002, 105, 1503-1508.
10. Mamcarz A.: Nieme niedokrwienie. Czestość wystepowania, uwarunkowania kliniczne i prognostyczne znaczenie w trzech grupach pacjentów. Praca habilitacyjna. Dział Wydawnictw Akademii Medycznej, Warszawa, 2001.
11. Zabalgoitia M., Ismaeil M.F., Anderson L. i wsp.: Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am. J. Cardiol., 2001, 87, 320-323.
12. Mamcarz A.: Nieme niedokrwienie u chorych z cukrzyca insulinoniezalezna̧ - czestość wystepowania, uwarunkowania kliniczne i metaboliczne. Pol. Przegl. Kardiol., 2001, 3, 297-303.
13. ACC/AHA Guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Exercise Testing). J. Am. Coll. Cardiol., 1997, 30, 260-311.
14. Stern S., Tzivoni D.: Early detection of silent ischemic heart disease by 24-hour electrocardiographic monitoring of active subjects. Br. Heart J., 1974, 36, 481-486.
15. Ahluwalia G., Jain P., Chugh S.K. i wsp.: Silent myocardial ischemia in diabetics with normal autonomic function. Int. J. Cardiol., 1995, 48, 147-153.
16. Airaskinen K.E., Koistinen M.J.: Association between silent altery disease, diabetes, and autonomic neuropathy. Fact or fallacy? Diabetes Care, 1992, 15, 288-292.
17. Kurpesa M., Krzemińska-Pakuła M., Kośmider M.: Przemijajace epizody niedokrwienia rejestrowane poza strefa zawału - obciȧzaja rokowanie. Kardiol. Pol., 1995, 42, 97-101.
18. Cohn P.F.: Asymptomatic coronary artery disease: patophysiology, diagnosis, management. Mod. Concepts Cardiovasc. Dis., 1981, 50, 55-59.
19. Annonu A.K., Fattah A.A., Mokhtar M.S. i wsp.: Left ventricular systolic and diastolic functional abnormalities in asymptomatic patients with non-insulin-dependent diabetes mellitus. J. Am. Soc. Echocardiogr., 2001, 14, 885-891.
20. Asakawa H., Fukui T., Tokunaga K. i wsp.: Plasma brain natriuretic peptide levels in normotensive Type 2 diabetic patients without cardiac disease and macroalbuminuria. J. Diabetes Complications, 2002, 16, 209-213.
21. Naka M., Hiramatsu K., Aizawa T. i wsp.: Silent myocardial ischemia in patients with non-insulin dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am. Heart J., 1992, 123, 46-53.
22. MiSAD Group: Prevalence of unrecognised silent myocardial ischemia and its association with atherosclerosis risk factors in non-insulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes. Am. J. Cardiol., 1997, 79, 134-139.
23. Zarich S.W., Waxman S., Freeman R.T. i wsp.: Effect of autonomic nervous system dysfunction of the circadian pattern of myocardial ischemia in diabetes mellitus. J. Am. Coll. Cardiol., 1994, 24, 956-962.
24. Deedwania P.C., Carbajal E.V.: Usefulness of ambulatory silent myocardial ischemia added to the prognostic value of exercise parameters in predicting risk of cardiac death in patients with stable angina pectoris and exercise-induced myocardial ischemia. Am. J. Cardiol., 1991, 68, 1279-1286.
25. Topol E.J., Travill T.A., Fortuin N.J. i wsp.: Hypertensive hypertrophic cardiomyopathy of the elderly. N. Engl. J. Med., 1985, 312, 277-283.
26. Souter R., Wohlgerernter D., Vita N.A.: Intact systolic left ventricular function in clinical congestive heart failure. Am. J. Cardiol., 1985, 55, 1032-1036.
27. Shimizu M., Sugihara N., Kita Y.: Increase in left ventricular chamber stiffness in patients with non-insulin dependent diabetes mellitus. Jpn. Circ. J., 1991, 55, 657-663.
28. Poirier P., Bogaty P., Garneau C. i wsp.: Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care, 2001, 24, 5-10.
29. Sanchez-Barriga J.J., Rangel A., Castaneda R. i wsp.: Left ventricular diastolic dysfunction secondary to hyperglycemia in patients with type II diabetes. Arch. Med. Res., 2001, 32, 44-47.
30. Pitale S.U., Abraira C., Emanuele N.V. i wsp.: Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM). Diabetes Care, 2000, 23, 1316-1320.
31. Rodriguez B., McNeill J.: The diabetic heart: metabolic causes for the development of a cardiomyopathy. Cardiovasc. Res., 1992, 26, 913-922.
32. Poirier P., Garneau C., Bogaty P. i wsp.: Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus. Am. J. Cardiol., 2000, 85, 473-477.
33. Yu C.M., Lin H., Yang H. i wsp.: Progression of systolic abnormalities in patients with "isolated" diastolic heart failure and diastolic dysfunction. Circulation, 2002, 105, 1195-201.